487 related articles for article (PubMed ID: 20957366)
41. CD34+ cell dose and CD33- subsets: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation.
Sampol Mayol A; Besalduch Vital J; Galmés Llodrá A; Bargay Lleonart J; Matamoros Flori N; Morey Sureda M; Novo García A; Mascaró Riera M; Gonzaléz Bach E; Martínez García P
Haematologica; 1998 Jun; 83(6):489-95. PubMed ID: 9676020
[TBL] [Abstract][Full Text] [Related]
42. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
Gandhi M; Jestice H; Scott M; Bloxham D; Bass G; Craig J; Marcus R
Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
[TBL] [Abstract][Full Text] [Related]
43. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease.
McQuaker I; Haynes A; Stainer C; Byrne J; Russell N
Bone Marrow Transplant; 1999 Oct; 24(7):715-22. PubMed ID: 10516673
[TBL] [Abstract][Full Text] [Related]
44. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
[TBL] [Abstract][Full Text] [Related]
45. Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis.
Rinn JP; Schwella N; Wollmer E; Jaques G; Heinzel-Gutenbrunner M; Strassmann G; Gross MW; Movassaghi K; Neubauer A; Ritter M
Ann Hematol; 2006 Jan; 85(1):38-44. PubMed ID: 16012838
[TBL] [Abstract][Full Text] [Related]
46. Using at least 5x10(6)/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation.
Scheid C; Draube A; Reiser M; Schulz A; Chemnitz J; Nelles S; Fuchs M; Winter S; Wickramanayake PD; Diehl V; Söhngen D
Bone Marrow Transplant; 1999 Jun; 23(11):1177-81. PubMed ID: 10382958
[TBL] [Abstract][Full Text] [Related]
47. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
48. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment.
Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL
Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272
[TBL] [Abstract][Full Text] [Related]
49. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
50. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
[TBL] [Abstract][Full Text] [Related]
51. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
[TBL] [Abstract][Full Text] [Related]
52. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
53. Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.
Watanabe T; Dave B; Heimann DG; Jackson JD; Kessinger A; Talmadge JE
Exp Hematol; 1998 Jan; 26(1):10-8. PubMed ID: 9430509
[TBL] [Abstract][Full Text] [Related]
54. The clearance time of infused hematopoietic stem cell from the blood circulation.
Donmez A; Ozsan F; Arik B; Ozkayin N; Cagirgan S; Mir S; Vural F; Tombuloglu M
Transfus Apher Sci; 2013 Apr; 48(2):235-9. PubMed ID: 23428427
[TBL] [Abstract][Full Text] [Related]
55. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
Hicks C; Trickett A; Kwan YL; Ramanathan S
Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
[TBL] [Abstract][Full Text] [Related]
56. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
[TBL] [Abstract][Full Text] [Related]
57. Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients.
Specchia G; Pastore D; Mestice A; Liso A; Carluccio P; Leo M; Casanova M; Sibilla S; Giannoccaro M; Liso V
Acta Haematol; 2006; 116(4):229-37. PubMed ID: 17119322
[TBL] [Abstract][Full Text] [Related]
58. The loss of CD34+ cells in peripheral hematopoietic stem cell products cryopreserved by non-controlled rate freezing and stored at -80 °C after overnight storage.
Donmez A; Yilmaz F; Soyer N; Cagirgan S; Arik B; Tombuloglu M
Transfus Apher Sci; 2014 Oct; 51(2):188-92. PubMed ID: 25217992
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts.
Lazarus HM; Sommers SR; Arfons LM; Fu P; Ataergin SA; Kaye NM; Liu F; Kindwall-Keller TL; Cooper BW; Laughlin MJ; Creger RJ; Barr PM; Gerson SL; Kaplan D
Biol Blood Marrow Transplant; 2011 Jul; 17(7):970-8. PubMed ID: 21440080
[TBL] [Abstract][Full Text] [Related]
60. CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation.
Aladağ Karakulak E; Demiroğlu H; Büyükaşik Y; Turgut M; Aksu S; Sayinalp N; Haznedaroğlu IC; Özcebe OI; Göker H
Turk J Med Sci; 2020 Dec; 50(8):1851-1856. PubMed ID: 32512672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]